Clinical Roundup Investigational Orca-T treatment for hematologic malignancies meets primary endpoint in phase III trial March 28, 2025Vol.51 No.12
Clinical Roundup UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma March 28, 2025Vol.51 No.12
Clinical Roundup Mutated cells can persist for years without becoming cancer and need an inflammatory “push” for malignancy to occur, COH study shows March 28, 2025Vol.51 No.12
Drugs & Targets FDA approves cabozantinib for patients 12 and up with pNET and epNET March 28, 2025Vol.51 No.12
News Analysis Trump’s tariffs will likely affect cancer drugs and devices—and may deepen drug shortages March 21, 2025Vol.51 No.11By Claire Marie Porter and Jacquelyn Cobb
White House Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism March 21, 2025Vol.51 No.11By Paul Goldberg
Guest Editorial Rathmell: We need a “March Madness” for cancer research“Cancer is a tremendously challenging tournament, but we are in it to win” March 21, 2025Vol.51 No.11By W. Kimryn Rathmell
Guest Editorial Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care March 21, 2025Vol.51 No.11By Jamillah Hoy-Rosas
In Brief The University of Rochester Wilmot Cancer Institute earns NCI Cancer Center designation March 21, 2025Vol.51 No.11
